AbbVie (ABBV) Common Equity (2012 - 2026)
AbbVie (ABBV) reported Common Equity of -$5.94 billion for Q2 2026, compared with -$138 million a year earlier.
Powered by 
Analysis
AbbVie (ABBV) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie posted Common Equity of -$3.27 billion.
- By year, Common Equity came in at $3.36 billion in FY2024 (-67.6%), $10.4 billion in FY2023 (-39.9%), $17.29 billion in FY2022 (+12.0%) and $15.44 billion in FY2021 (+17.9%).
- Five-year quarterly Common Equity spans a low of -$6.61 billion in Q1 2026 and a high of $17.29 billion in Q4 2022.
- The high point for year-over-year Common Equity in five years was Q1 2022 (growth of 18.8%); the low point was Q1 2025 (a decline of 81.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$6.61 billion (Q1 2026), -$3.27 billion (Q4 2025) and -$2.64 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.94 Bn |
| Mar 31, 2026 | -6.61 Bn |
| Dec 31, 2025 | -3.27 Bn |
| Sep 30, 2025 | -2.64 Bn |
| Jun 30, 2025 | -138.00 Mn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 3.36 Bn |
| Sep 30, 2024 | 6.07 Bn |
| Jun 30, 2024 | 6.82 Bn |
| Mar 31, 2024 | 8.05 Bn |
| Dec 31, 2023 | 10.40 Bn |
| Sep 30, 2023 | 12.13 Bn |
| Jun 30, 2023 | 12.90 Bn |
| Mar 31, 2023 | 13.30 Bn |
| Dec 31, 2022 | 17.29 Bn |
| Sep 30, 2022 | 16.03 Bn |
| Jun 30, 2022 | 14.69 Bn |
| Mar 31, 2022 | 16.31 Bn |
| Dec 31, 2021 | 15.44 Bn |
| Sep 30, 2021 | 13.58 Bn |
API Access
AbbVie Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();